Neoadjuvant therapy of locally advanced gastric cancer.
作者： James J. Mezhir , Laura H. Tang , Daniel G. Coit
DOI: 10.1002/JSO.21483
关键词:
摘要: Treatment of gastric cancer has evolved with the advent randomized trials demonstrating chemotherapeutic agents efficacy in advanced disease. Level I evidence supports delivering chemotherapy neoadjuvant setting; data shows improvement progression-free and overall survival. A clinical response to therapy is associated improved R0 resection rates, pathologic response, outcome patients locally Early assessment metabolic can potentially be utilized tailor treatment. J. Surg. Oncol. 2010; 101:305–314. © 2010 Wiley-Liss, Inc.
sci-hub.se 参考文章(61)
J.E de Vries, J.A Wils, J van der Bijl, J.H.J.M van Krieken, H.H Hartgrink, C.J.H van de Velde, H Putter, I Songun, M.E.T Tesselaar, E.Klein Kranenbarg, Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial. Ejso. ,vol. 30, pp. 643- 649 ,(2004) , 10.1016/J.EJSO.2004.04.013
Michael Stahl, Martin K. Walz, Martin Stuschke, Nils Lehmann, Hans-Joachim Meyer, Jorge Riera-Knorrenschild, Peter Langer, Rita Engenhart-Cabillic, Michael Bitzer, Alfred Königsrainer, Wilfried Budach, Hansjochen Wilke, Phase III Comparison of Preoperative Chemotherapy Compared With Chemoradiotherapy in Patients With Locally Advanced Adenocarcinoma of the Esophagogastric Junction Journal of Clinical Oncology. ,vol. 27, pp. 851- 856 ,(2009) , 10.1200/JCO.2008.17.0506
Katja Ott, Wolfgang A. Weber, Florian Lordick, Karen Becker, Raymonde Busch, Ken Herrmann, Hinrich Wieder, Ulrich Fink, Markus Schwaiger, Jörg-Rüdiger Siewert, Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction. Journal of Clinical Oncology. ,vol. 24, pp. 4692- 4698 ,(2006) , 10.1200/JCO.2006.06.7801
Jaffer A. Ajani, Kathryn Winter, Gordon S. Okawara, John H. Donohue, Peter W.T. Pisters, Christopher H. Crane, John F. Greskovich, P. Rani Anne, Jeffrey D. Bradley, Christopher Willett, Tyvin A. Rich, Phase II Trial of Preoperative Chemoradiation in Patients With Localized Gastric Adenocarcinoma (RTOG 9904): Quality of Combined Modality Therapy and Pathologic Response Journal of Clinical Oncology. ,vol. 24, pp. 3953- 3958 ,(2006) , 10.1200/JCO.2006.06.4840
P. Sun, J.-B. Xiang, Z.-Y. Chen, Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer British Journal of Surgery. ,vol. 96, pp. 26- 33 ,(2008) , 10.1002/BJS.6408
Michael W Kattan, Martin S Karpeh, Madhu Mazumdar, Murray F Brennan, None, Postoperative Nomogram for Disease-Specific Survival After an R0 Resection for Gastric Carcinoma Journal of Clinical Oncology. ,vol. 21, pp. 3647- 3650 ,(2003) , 10.1200/JCO.2003.01.240
Abeezar I. Sarela, Robert Lefkowitz, Murray F. Brennan, Martin S. Karpeh, Selection of patients with gastric adenocarcinoma for laparoscopic staging The American Journal of Surgery. ,vol. 191, pp. 134- 138 ,(2006) , 10.1016/J.AMJSURG.2005.10.015
Karl-Gunnar Janunger, Larsolof Hafström, Bengt Glimelius, Chemotherapy in gastric cancer: a review and updated meta-analysis European Journal of Surgery. ,vol. 168, pp. 597- 608 ,(2002) , 10.1080/11024150201680005
D Kelsen, M Karpeh, G Schwartz, H Gerdes, C Lightdale, J Botet, G Lauers, D Klimstra, Y Huang, L Saltz, V Quan, M Brennan, Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil. Journal of Clinical Oncology. ,vol. 14, pp. 1818- 1828 ,(1996) , 10.1200/JCO.1996.14.6.1818
Adams Bg, Crea P, Stephens Fo, Intra-arterial chemotherapy given preoperatively in the management of carcinoma of the stomach. Surgery gynecology & obstetrics. ,vol. 162, pp. 370- 374 ,(1986)